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Received 23 June 2012; revised 7 September 2012; accepted 1 October 2012AbstractDespite the acceptance of physical activity (PA) being integral to a young person’s health, children with disability often exhibit low levels of
PA. In young people with cystic fibrosis (CF) the importance of exercise and daily PA is acknowledged by clinicians and their support teams,
however, there is a lack of knowledge related to its prescription. CF is a recessive genetic disorder affecting the lung, pancreas and sweat glands.
CF is the most common life shortening genetic disease in the Caucasian population for which there is no cure. In the UK, CF affects over 9000
people, with 4000 under 16 years of age. Only about half of the CF population can expect to live beyond 40 years of age. Besides drug therapies,
rehabilitative exercise programmes form an important component of treatment and long term exercise programmes are considered positive
treatment strategies, but all lack any detailed prescriptive information. Several reviews and editorials have highlighted the lack of evidence based
research in PA and exercise training in young people with CF; but advocate a greater need for understanding the role of exercise in therapeutic
interventions. The purpose of this review is to update the reader on the current recommendations and evidence in PA and exercise training for
young people with CF. These developments have extended our understanding of PA and exercise training in children and adolescents with CF,
and its implementation in the management of this chronic disease.
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Cystic fibrosis (CF) is an autosomal recessive genetic
disorder affecting a number of body systems, including the
lung, pancreas and sweat glands. The basic defect in CF is
a disruption in the CF transmembrane conductance regulator
(CFTR).1 The mutated CFTR causes a decrease in chloride ion* Corresponding author.
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http://dx.doi.org/10.1016/j.jshs.2012.11.002conductance across the apical membrane of the epithelial
cells, resulting in sweat that is high in sodium and chloride
levels, and mucus that is abnormally thick and viscous.2
Mucus in the pancreas and gastrointestinal tract results in
insufficient secretion of digestive enzymes and malabsorption
of nutrients.3 Nutritional deficiencies lead to decreased fat
stores and, as a result of protein malnutrition, muscle
wasting.4,5 In the lungs the increased viscosity of mucus and
its retention causes bronchial obstruction, recurrent or chronic
infections, and finally respiratory failure. In more thanw95%
of all CF patients impaired respiratory function with hyper-
capnia, chronic hypoxaemia, and exhaustion of the respiratory
muscles is the eventual cause of death.6
In addition to the control of chronic infection, airway
clearance techniques, such as chest physical therapy and
postural drainage, have been conventionally used in the
management of CF to release mucus from the airways of theng by Elsevier B.V. Open access under CC BY-NC-ND license.
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mucus clearance, with the intention to prevent recurrent lung
infection. Moreover, physical activity (PA) and exercise
training in CF have been reported to improve or slow down the
rate of decline of important prognostic indicators such as lung
function and aerobic fitness. Research from our children’s
centre, amongst other centres around the world, have shown
that children and adolescents with CF have a reduced ability to
tolerate exercise.8,9 This has serious implications for their
well-being and quality of life (QoL) and limits the opportu-
nities for their involvement in sports and recreational activi-
ties. This is critical as aerobic fitness has been shown to be
a key predictor of disease prognosis and mortality in patients
with CF, independent of factors such as age, sex, lung func-
tion, and nutritional status.10 Understanding the efficacy of
using exercise training to promote PA, physical fitness, well-
being, and longevity is therefore critical in young people with
CF. However, in a recent survey it was shown that clinicians
and their multidisciplinary teams, whilst valuing exercise
prescription, knew little about how to implement it in prac-
tice.11 In the UK current recommendation by the Cystic
Fibrosis Trust12 advocates the use of exercise, but it is poorly
and sporadically implemented nationally and lacks detail
concerning the most appropriate exercise intensity and dura-
tion, and how this can be implemented alongside other aspects
of routine clinical support (i.e., nutritional and psychological).
The implementation of an improved evidence based exer-
cise prescription programme will, undoubtedly, improve the
quality of clinical care and practice.13 Therefore, several key
publications highlight the timeliness of this type of work and
its potential impact on a national and international stage.14,15
Adherence is a key outcome for the success of any training
programme, and is one reason why many studies fail to report
significant improvements in physiological and psychological
performance. By including a psychosocial element to
a training programme, adherence may be improved but this
has yet to be tested within the CF population. A recent
supervised physiotherapy outpatient exercise programme
showed excellent improvements in QoL, reduction in antibi-
otic days and some improvements in exercise capacity, despite
no significant changes in body mass index (BMI).16
Accounting for these factors, researchers will be able to
monitor the combined effect of exercise, psychological and
nutritional support, and should be able to be precise about the
magnitude of the training response. The aim of this review
paper is to present the reader with the current recommenda-
tions and evidence in PA and exercise training for young
people with CF.
2. Recommendations and evidence for PA in young people
with CF
PA is defined as a behavior trait and subject to multiple
extraneous factors.17 In young people with CF the burden of
lung disease can impact on PA levels. Indeed, patients with CF
attend regular clinic appointments, comply with drug therapy
and physiotherapy sessions, and may miss school due toincreased illness and/or pulmonary exacerbation. The burden
of lung disease may reduce the opportunities to be active on
a regular basis, and cause the PA patterns of young CF patients
to become irregular. In 2004, recommendations on PA and
health for healthy children were re-affirmed by the UK’s Chief
Medical Officer.18 These guidelines have since been further
reviewed by researchers in the United States who concluded
that school children should engage in at least 1 h of moderate
to vigorous activity per day, and that activities should be
enjoyable and developmentally suitable. More recent updates
on the PA guidelines for healthy children in the UK have been
issued.19 However, one key point the UK group commented on
was the lack of PA data for children with chronic diseases.
Therefore, as a minimum when data are being collected on
physical fitness of patients with CF, PA data should also be
collected. Preferably the PA measurements should include
both questionnaire, as well as, more objective measures such
as accelerometry.
Comprehensive reviews on the measurement and assess-
ment procedures have broadly defined the PA patterns of
healthy young people and adults.20,21 However, for children
with CF the evidence is less well established. In healthy young
people, irrespective of instrument or device to measure PA,
similar results have been found. Firstly, boys are more active
than girls; secondly, activity declines with age; and thirdly, the
relationship between fitness and activity becomes stronger
with increasing age. The latter finding is important because it
has yet to be conclusively shown that PA is a strong predictor
for fitness in healthy young people as it is in adults. Although
it has yet to be definitively established in childhood diseases, it
is likely that the relationship between fitness and activity is
stronger because of the connection between the disease
progression and physical function. In adults, the two measur-
able outcomes, activity and fitness, are linked to morbidity and
mortality and the association is even stronger. For children and
adolescents with CF, the associations between health, activity,
and fitness are important to understand in order to establish
how these variables impact on the disease processes. Similarly,
CF clinicians and their support teams wish to know and
understand more about fitness and PA as these two variables
are often used as part of the management and care of their
patients.11 In young CF patients it has been shown that
maintaining high levels of fitness can have a significant impact
on mortality.10
Children with mild to moderate CF can be active but often
choose not to be. This is due to a range of reasons, including
parental overprotection, fear on the part of the child, lack of
understanding of the disease by teachers and healthcare
professionals, self or peer imposed social isolation,22 as well
as, perceptions of “no time to play”.23 For the CF child it is
important to be as active as possible from the beginning of
their lives because when the progression of the disease
becomes severe, the disease will itself become a direct cause
of their hypoactivity. This pattern creates a cycle of ensuing
hypoactivity leading to deconditioning within the body
systems, leading to further deterioration in physical function
that causes further hypoactivity. Therefore, it is imperative that
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management of the disease. Although the use of exercise will
not affect the pathophysiological process of CF, it will bring
significant benefits to the CF patient.
Longitudinal measures of PA in young people with CF are
not common, but one study by Schneiderman-Walker and
colleagues24 showed for females 7e17 years of age that those
in the two bottom quartiles suffered a more rapid rate of
decline in forced expiratory volume in 1 s (FEV1) than girls in
the top two quartiles. In boys with CF, there was no significant
relationship found between PA and FEV1 decline. It is
generally known that healthy boys are more physically active
than girls, and this is likely even in young males with CF and
might explain poorer survival rates of female CF patients.
Other studies have found lower25 and similar26,27 PA levels
compared to healthy children. The study by Britto and
colleagues26 noted that adolescents with CF did not differ
significantly when asked to recall participating in three or
more activities a week which made them “sweat or breathe
hard”. When adjustments were made by gender and health
status, adolescents aged <14 years of age and between 15 and
16 years of age were more likely to participate in activities
three times per week compared to adolescents aged >17 years
of age. This is not uncommon in normal healthy children, but
does suggest that adolescents making the transition to adult
care need to be reminded to increase their PA levels.
Apart from age effects, Selvadurai and colleagues28 found
that, like healthy children, puberty in CF affects the level of
PA. When matched with prepubertal controls, boys and girls
with CF had similar levels of PA. However, after puberty PA
was higher in boys with CF compared to girls, although,
interestingly, children with mild CF had higher levels of PA
when compared to controls. When the PA of moderate and
severe CF was compared to controls, however, PA was lower.
These observations no doubt reflect the importance of the
management of exercise when the disease progression is
minimal compared to the incidental affects of the disease as it
progresses more rapidly and hypoactivity is increased.
To the best of our knowledge only one study has recom-
mended a more vigorous promotion of PA.25 Using Kriska’s
Modifiable Activity Questionnaire (MAQ) to measure habitual
activity, in patients with the worst lung disease, vigorous
activity was significantly and positively related to peak oxygen
uptake ð _VO2peakÞ (r ¼ 0.83, p < 0.05). Although vigorous
activity was less than when compared to healthy controls,
Nixon and colleagues25 suggested more vigorous activities
should be encouraged for CF patients in order to promote
aerobic fitness which may impact on survival rates. Despite PA
not being measured objectively, the findings of this study do
reflect the interlinked correlates between fitness, PA, and
morbidity which become more prominent as the disease
progresses from mild to severe status. However, caution must
be exhibited when inferring these results at an individual
patient level. Ruf and colleagues29 have shown when
measuring PA by a variety of questionnaires (Habitual Activity
Estimation Scale; 7-day Physical Activity Recall; Lipids
Research Clinics Questionnaire), as well as via accelerometryand testing aerobic fitness, that all the questionnaires were
unable to generate valid PA data and aerobic fitness on an
individual basis. All the associations were, at best, moderate
(0.32 < r < 0.56). Thus, using the questionnaires to advise PA
programmes for patients with CF would be imprecise and
should, at the minimum, be based on objective measures
captured through accelerometry. For those clinics unable to
afford accelerometers, a recent study published in the Journal
of Cystic Fibrosis has reported that less expensive pedometers
could be used to indicate significant changes in health status
and self reported activity.30 However, further research is
required to validate these findings, as 12 of 30 (40%) CF
participants had a decrease in their measured step rate when
well, compared to when ill (as assessed by the high standard
deviation of the mean step rates).
In summary, more data are required before PA recom-
mendations for young people with CF can be supported.
Whilst the potential benefits of habitual PA and exercise are
known, the lack of guidelines and recommendations are
holding back many young patients and their families enjoying
these benefits. Given the relative inexpensive cost of the many
opportunities to increase PA, exercise prescription needs to
occupy a more central role in the therapeutic intervention of
young CF patients. Therefore, the challenge to researchers is
to acquire more evidence based practice of the cost-benefit of
PA and exercise interventions.
3. Recommendations and evidence for exercise training in
young people with CF
The use of exercise training programmes to maintain or
improve physiological health outcomes in young people with
CF requires further investigation. In this section we refer to
exercise training in the context of PA which is above and
beyond normal habitual movement. In this scenario, the
increased levels of PA, or exercise, are completed with
a purpose to improve function, whether physiological or
psychological. At present, evidence to suggest that participa-
tion in exercise training programmes can improve the health
of the young CF patient is limited, and there is a lack of the
highest, or level 1, evidence (i.e., randomised controlled trials
(RCTs)) to support empirical data and validate conclusions.15
However, there is some high level evidence to suggest that
both aerobic and strength training programmes can have
a positive impact (e.g., improve or maintain important clinical
markers) on patient health. There are currently five robust
RCTs that have investigated the impact of exercise training on
pulmonary function, aerobic fitness, and muscular strength in
young people with CF.24,31e34 These studies all included the
following criteria: subjects aged 6e18 years of age all diag-
nosed with CF by a medical professional; the exercise inter-
vention was at least 2 weeks in duration, and described in
sufficient detail to be repeated; the randomised grouping of
control and treatment subjects; and a control group receiving
routine medical care and no additional formal exercise
training, with the exception of the study by Orenstein et al.32
Any attempts to amalgamate the results of these studies,
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frequency, intensity and duration of the exercise intervention
and initial disease severity of the patients. Another aspect
lacking to these RCTs was a very singular focus on either
aerobic or strength training in their respective programmes. In
reality for programmes to be successful and to increase
adherence, programmes should look to be multi-faceted and
should incorporate aspects of psychological and nutritional
support so that a more holistic approach is provided. The
results of these RCTs are summarised in Table 1.
From a clinical perspective, the studies by Sosa et al.34 and
Selvadurai et al.33 provide evidence for the use of supervised
in-hospital exercise training in the treatment of patients
admitted for pulmonary exacerbation; which can be defined as
a worsening of patient symptoms, including an increase in
cough, sputum production, dyspnoea and fatigue, and more
objective measures such as decline in pulmonary function,
fluctuation in core temperature, and weight loss. Selvadurai
and co-workers33 reported that, compared to the control group,
both aerobic and resistance training resulted in significant
improvements in FEV1 at discharge and 1 month following;
subjects in the aerobic training arm also demonstrated mark-
edly greater improvements in exercise capacity (i.e., _VO2peakÞ
at discharge and 1 month after, compared with resistance
training and controls. This study provides support that exercise
training, particularly aerobic, may have a useful role on the in-
patient ward for the treatment/rehabilitation of pulmonary
exacerbation.
The study by Sosa and colleagues34 assessed the effects of
an 8-week in-hospital exercise programme that combined
circuit weight and aerobic training. Significant increases in
_VO2peak were observed in the training group by 3.9 mL/kg/min;
and improvements in five rep-max bench press, leg press and
seated row were all significantly greater in the training group.
A novel approach to the study by Sosa and co-workers34 is the
inclusion a 4-week detraining period. During the detraining
period, in the training group _VO2peak decreased by a compa-
rable magnitude to baseline, however, all significant
improvements in five rep-max outcomes from the training
period were retained. No significant changes in pulmonary
function, BMI, fat-free mass and body mass were reported
during the training and detraining period in either the training
or control group. Maintaining or improving pulmonary
function and aerobic capacity, and slowing down the annual
rate of decline in FEV1 and _VO2peak is important as both are
strong predictors of survival for children with CF.10,35
Therefore, any intervention that can impact positively on
these health outcomes would be of potential benefit to patient
prognosis; however, it is still not known whether exercise
training can improve survival.
Schneiderman-Walker et al.24reported that a 3-year unsu-
pervised aerobic training programme resulted in significantly
less annual decline in forced vital capacity (FVC) than the
control group receiving usual care, however, no difference in
the annual rate of decline of _VO2peak was observed. Klijn
et al.31 has presented data to support the use of anaerobic
training in children with CF to significantly improve both_VO2peak and anaerobic power. This supervised 3-month
anaerobic training program resulted in significant improve-
ments in peak power (watts) which were maintained over
a 12-week period post training. The longest exercise pro-
gramme duration of the five RCTs was conducted by Oren-
stein et al.32 These investigators compared the impact of
aerobic and strength training over a 6- and a 12-month period.
The results of the RCT showed that both aerobic and strength
training can significantly improve leg muscle strength, whilst
pulmonary function is maintained. To control for changes in
body mass of subjects over the 6- and 12-month period,
muscular strength was adjusted for changes in body mass over
time.
The only RCT that reported significant improvements in
both pulmonary function and aerobic fitness was Selvadurai
et al.’s33 study conducted in a supervised in-hospital setting.
RCTs by Schneiderman-Walker et al.24 and Orenstein et al.32
reported no chances in aerobic fitness from exercise training;
moreover, Orenstein et al.32 reported a significant reduction in
aerobic fitness from 6 months of strength training. This might
be attributed to low adherence reported by Orenstein and co-
workers, and the unsupervised nature of the exercise pro-
gramme of Schneiderman-Walker and colleagues.24 Further-
more, no changes in pulmonary function were observed by
Orenstein et al.32 over the 6- and 12-month period, which,
again, may be attributed to the lack of adherence. When
compliance was reported to be high, however, a significant
protective effect on FVC was shown.24 Klijn and co-workers31
reported from their 3-month anaerobic training programme no
significant changes in pulmonary function or aerobic fitness;
however, the control group demonstrated a significant fall in
aerobic fitness over the training period.
Despite a wide divergence between the RCTs in duration,
setting and disease severity of participants, the evidence
shows that none of the exercise training programmes had
a negative effect on pulmonary function or muscular strength,
and the fall in aerobic fitness of the strength group at 6 months
of a 12-month exercise programme reported by Orenstein
et al.32 may have been due to poor compliance. The RCT by
Selvadurai et al.33showed great promise for the value of
exercise training in children with CF, with significant
improvements reported in pulmonary function, aerobic fitness
and strength from the exercise groups. It must be taken into
consideration that these subjects entered the study with
pulmonary exacerbation, increasing the likelihood of
a training affect, and masked by the medications received
whilst in hospital. However, no significant improvements were
reported in the control group, and, in fact a significant decline
in FEV1 was shown over the 19-day training period in the
control group.
It is encouraging that all exercise programmes, including
a strength training component, reported increases in leg
strength in the children with CF.24,31e34 Only in the study by
Selvadurai et al.33 was this increase not reported as being
statistically significant. These data show that improvements in
leg strength can be achieved by both short- and long-term
training and of moderate to high intensity. CF is characterised
Table 1
Exercise training programmes in young people with cystic fibrosis: randomised controlled trials.
Study Exercise training programme Pulmonary function Aerobic fitness Muscular strength Anaerobic fitness
Group (n) Frequency Intensity Duration FEV1 (% predicted) FVC (% predicted) _VO2peak Leg strength Peak power (w)
% D
pre-post
p-value % D
pre-post
p-value mL/kg/min
D pre-post
p-value % D
pre-post
p-value % D
pre-post
p-value
Schneiderman
-Walker
et al. (2000)24
Control (n ¼ 36) e e 3 years 3.47 (4.93) NR 2.42 (4.15) NR 1.85 (2.51) NR e e e e
Aerobic (n ¼ 36) 3  30 min/week 70%e80% HRmax e 1.46 (3.55) NR 0.25 (2.81) NR 1.80 (2.21) NR e e e e
Selvadurai
et al. (2002)33
Control (n ¼ 21) e e 19 days 4.51 (6.90) <0.05 2.28 (4.22) NS 1.22 (6.15) NS 6.30 (6.10) NS e e
Aerobic (n ¼ 21) 5  30 min/week 70% HRmax e 6.54 (7.76) <0.05 2.34 (4.62) NS 7.31 (6.29) <0.01 1.83 (6.23) NS e e
Resistance
(n ¼ 22)
5  10 reps 70% max
resistance
e 10.09 (7.43) <0.01 2.45 (4.18) NS 0.73 (5.89) NS 18.32 (7.02) <0.01 e e
Klijn et al.
(2004)31
Control (n ¼ 9) e e 12 weeks NR: no significant
change within or
between groups
e e 0.6 (1.9) <0.05 e e e e
Anaerobic
(n ¼ 11)
2  (30e40)
min/week
High e e 1.5 (2.6) NS e e 11.7 <0.001
Orenstein
et al. (2004)32
Aerobic (n ¼ 26) 3  30 min/week 70% HRmax 6 months 2.78 NS e e 1.91 NS 2.69 0.003 e e
Strength (n ¼ 30) 3 sessions/week <55% HRmax 1.3 NS e e 2.16 <0.01 4.69 <0.001 e e
Aerobic (n ¼ 25) 3  30 min/week 70% HRmax 12 months 4.68 NS e e 0.91 NS 5.13 <0.001 e e
Strength (n ¼ 28) 3 sessions/week <55% HRmax e 0.97 NS e e 1.73 NS 6.4 <0.001 e e
Sosa et al.
(2012)34
Control (n ¼ 11) e e e 5.6 (L/s) NS 3.1 (L) NS 2.2 NS w4 <0.01 e e
Weight & aerobic
(n ¼ 11)
3 sessions/week 1  12e15 reps
(11 exercises)
20e40 min cycling
at ventilatory
threshold
8 weeks 3.7 (L/s) NS 3.3 (L) NS 3.9 0.002 24.9 0.002 e e
Abbreviations: FEV1 ¼ forced expiratory volume in 1 s; FVC ¼ forced vital capacity; _VO2peak ¼ peak oxygen uptake; HRmax ¼ heart rate maximum; NR ¼ not reported; NS ¼ not significant.
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44 C.A. Williams and D. Stevensby pancreatic insufficiency and malabsorption of nutrients,
leading to deterioration in fat and muscle mass. Therapeutic
interventions, such as exercise training programmes, that can
improve muscular strength and size, will not only improve the
functional capacity of the young CF patient, but have been
shown to correlate strongly with improved prognosis.10 It is
also particularly encouraging that data from Sosa and co-
workers34 showed that improvements in muscular strength can
be maintained during a 4-week detraining period, and that
continuous improvements in leg strength can be achieved over
a 6- and a 12-month training period.
Improvements in QoL have been reported in children with
CF participating in exercise training programmes. Selvadurai
et al.33 used the Quality of Well Being Scale to measure QoL
pre- and post-1-month following aerobic training, resistance
training and in controls. A significant improvement in QoL
was reported 1 month later in the patients who had partici-
pated in the aerobic exercise training programmes whilst in
hospital. However, no significant improvements in QoL were
reported from the resistance training or control groups. The
findings of this study show that improvements in QoL only
reached statistical significance in the aerobic training group,
where _VO2peak significantly increased, are consistent with the
findings of Orenstein et al.,36 in that, QoL correlates better
with changes in aerobic fitness than changes in pulmonary
function. This emphasises the importance of cardiopulmonary
exercise testing, as not only does it provide important clinical
information of the impact of the disease over time, but also
the impact of the disease on the patient’s QoL. Klijn et al.31
used a disease specific QoL questionnaire, the CF question-
naire; which takes into account the different developmental
stages, and makes it possible to measure the health status and
QoL of patients aged 6 years of age through to adulthood. At
the end of the 12-week anaerobic training programme,
a significantly higher score was found in the domain of
physical functioning on the CF questionnaire in the training
group, but no change was found in the control group or in
other QoL domains.
Despite the lack of RCTs designed to investigate the
physiological effects of exercise training programmes, the
reviewed RCTs provide good evidence that pulmonary func-
tion, exercise capacity, and muscular strength can be improved
in young people with CF by participation in exercise training
programmes. This has important implications for patient
prognosis in young people with CF. The best improvements in
these parameters have been derived from in-patient supervised
exercise training programmes.31,33,34 Indeed, this in-patient
hospital study was the only study to report significant
improvements in both pulmonary function and exercise
capacity.33 Patient adherence to the exercise training pro-
gramme may have been an important factor in these studies.
Aerobic training has been shown to improve pulmonary
function, and slow down its annual rate of decline; however,
improvements in _VO2peak from exercise training are unclear.
Aerobic fitness improved during a short duration of aerobic
training33 and an 8-week programme that combined both
weight training and aerobic exercise,34 but not with any otherform of aerobic training. This is likely due to the typical error
of _VO2peak testing for which at least a 10% change from pre- to
post-test score is required for it to be of a sufficient magnitude
to declare a clinically meaningful change.37 Changes in
muscular strength from exercise training showed the most
improvement, and showed increases with strength/resistance,
anaerobic and aerobic training.
In summary, there is great potential for further research in
this area to determine the most effective exercise programme
for children with CF. Indeed, large improvements in muscu-
lature have been shown with strength training; and the study of
weight and resistance programmes regarding intensity and
dose response relationships hold much promise.
To date there have been very few attempts to combine
physiological, psychological, and nutritional interventions in
training studies of young CF patients.15 The likely benefits to
the patients include clinical improvements in health sta-
tus.38e40 Clinical improvements in exercise capacity, lung
function, self-efficacy, competence, and self-confidence and
thus QoL are all accompanied by improvements brought about
by training.24,33,40e42 This has important implications to the
cost-benefit of exercise prescription in CF management.
Indeed, in one study an antibiotics saving of £66,000 over 1
year was attained.33 As a consequence of these clinical
improvements hospital admissions and antibiotic prescriptions
are reduced, school attendance increases, self confidence
when exercising increases, the young patient is empowered to
participate in physical education and games with their peers
on a more regular basis, and their social life can be signifi-
cantly enhanced. However, more empirical data, followed by
RCTs, will begin to help the clinical team assess the cost-
benefit of the long term exercise interventions. In other
countries, lessons from Chronic Obstructive Pulmonary
Disease (COPD) training models have also been transferred to
CF programmes. These analyses will help determine the
sustainability of the programme and the clinical and economic
benefits.43
Several studies have highlighted that healthcare providers
need to be better educated in PA promotion and exercise
training prescription, and implementing both in clinical prac-
tice.39,44 A new integrated exercise training model of care
would significantly improve the quality of clinical practice, by
improving clinical outcomes and translating into longer term
survival and QoL prospects, is needed in the management of
young people with CF.45e47
4. Conclusion
Clinicians and their support teams recognise the value of
PA and exercises training in the therapeutic intervention for
young people with CF. However, these teams are unsure about
how best to implement its use amongst their paediatric
patients. There is currently not enough detailed physiological
information to prescribe programmes of sufficient duration,
intensity and frequency in which to affect clinical outcomes.
Additionally, little is known about the effects of exercise
programmes on bone health and CF related diabetes, and more
Exercise promotion in young CF patients 45work should be directed at investigating how exercise can
improve and control these outcomes. The impact of exercise
training programmes on other physiological outcomes such as
patient symptoms, nutritional status, bacteria colonisation and
QoL requires more attention. Determining the effects of
exercise training post lung transplantation would also be an
important area of future study. Furthermore, strategies to
improve adherence to exercise training in children with CF are
needed to realise the full potential of exercise programmes as
therapeutic interventions.
Currently, a broad approach to increasing or maintaining PA
of an aerobic and strength basis is the best that can be
prescribed. However, there are some convincing data which
show savings related to hospital admissions and reduced costs
in medication, as well as, improvements in current disease
status. As more of this type of evidence is provided, the relative
low cost of implementing exercise programmes will be seen
even more favourably. The provision of this type of evidence
should act as a driver to investigate more comprehensively the
efficacy of exercise prescription tailored to each patient’s needs.
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